Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
Tennessee Cannabis Market Stalled as Nashville Remains Delta-8 Only
Tennessee's restrictive cannabis laws limit Nashville market to hemp-derived products, creating revenue gap as neighboring states advance legalization efforts.
Cannabis Beverages Emerge as America's Next Growth Category
Cannabis-infused drinks gain mainstream traction as consumers seek alternatives to alcohol, creating new revenue streams for operators nationwide.
Texas Cannabis Reform Momentum Could Unlock $2B+ Market Opportunity
Growing border state pressure and local decriminalization efforts signal potential regulatory shifts that could reshape the nation's second-largest cannabis market.
Blueberries Medical Surges 19% Despite Penny Stock Volatility
BBRRF climbs to $0.01 on elevated volume, highlighting ongoing challenges in international cannabis micro-cap space.
PharmaCielo Crashes 26% as Cannabis Stock Hits Near 52-Week Lows
PCLOF shares plummeted to $0.04 amid heavy selling pressure, bringing market cap down to just $7.4M as investors flee micro-cap cannabis names.
Greater Cannabis Company Crashes 36% on Heavy Volume Amid Concerns
GCAN shares plummeted to $0.12 as the micro-cap MSO faces mounting pressure near 52-week lows with limited financial transparency.
PNXP Stock Explodes 111% Despite Zero Price Point Trading
Pineapple Express Cannabis sees massive volume surge with 907K shares traded as stock maintains penny stock territory.
Canopy Growth Analyst Sets $40 Price Target on Cannabis Legalization Bet
Wall Street analyst projects 300% upside for CGC shares as federal cannabis reform momentum builds, citing regulatory tailwinds and market positioning.
Canopy Growth Bulls Eye 300% Upside Despite Sector Headwinds
Single analyst projects 4x returns for CGC stock as cannabis sector faces persistent bearish sentiment and operational challenges.
Cannabis ETFs Eye Dividend Strategies as Sector Matures
As cannabis companies generate steady cash flows, ETF providers explore dividend-focused strategies to attract income investors seeking exposure to the maturing sector.
Aurora Cannabis Stock Surges on Renewed Institutional Interest
ACB shares climb as institutional investors reassess cannabis sector valuations amid improving fundamentals and regulatory tailwinds.
Cannabis Cultural Shift Signals Broader Industry Acceptance Trends
Afroman's resurgent relevance reflects evolving cannabis perception, potentially supporting sector growth as cultural stigma diminishes and mainstream adoption accelerates.
NC Senate Restricts Hemp THC Products in Latest State Crackdown
North Carolina lawmakers advance legislation targeting hemp-derived THC and kratom sales, adding regulatory pressure on cannabis operators.
Healthcare ETF Battle Heats Up as Cannabis Investment Interest Grows
State Street's healthcare ETF outperforms Invesco's pharma fund on key metrics as institutional investors eye cannabis exposure through broader healthcare plays.
Cannabis Valuations Hit Multi-Year Lows as Oversold Conditions Emerge
Major MSOs trade at steep discounts despite operational improvements, creating potential value opportunities for contrarian investors.
Healthcare Investors Eye Cannabis Biotech Opportunities in 2026
Medical cannabis biotechnology emerges as alternative investment theme as traditional healthcare stocks face valuation pressures and regulatory headwinds.
Georgia Medical Cannabis Expansion Eyes 3x Patient Growth in First Year
New state law removes potency caps and expands delivery methods, positioning Georgia as emerging Southeast market for medical operators.
AI Diagnostics vs Cancer Therapy: Healthcare Investment Divergence
Healthcare investors weigh scaling AI diagnostic platforms against personalized cancer treatment revenues as sector valuations shift toward profitability metrics.
Consumer Healthcare Giant Eyes Cannabis Wellness Expansion Opportunities
Prestige Consumer Healthcare's acquisition strategy signals growing mainstream interest in cannabis-adjacent wellness products as regulatory barriers soften.
Healthcare ETFs Shift Focus as Cannabis Investment Options Expand
Traditional healthcare ETFs face new competition as cannabis-focused investment vehicles gain traction with institutional investors seeking exposure.